welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.
expertly curated content related to this topic
- ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer SyndromesThis guideline presents recommendations ...
- What’s New in Hereditary Colorectal Cancer?This editorial discusses practical sign...
- Diagnostic Values of Dual Focus Narrow Band Imaging and Probe-Based Confocal Laser Endomicroscopy in FAP-Related Duo...BACKGROUND AND STUDY AIMS : Familial ade...
- Genetic testing for hereditary cancer syndromesGenetic testing looks for specific inher...
- Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancerAbstractA 29-year-old female visited...
- Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal CancerExecutive Summary Colorectal Cancer con...
- Perinatal Detection of Familial Adenomatous PolyposisBACKGROUND : Hepatoblastoma is an uncomm...